| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.50▼ | 3.52▼ | 3.51▼ | 3.50▼ | 3.09▲ |
| MA10 | 3.52▼ | 3.52▼ | 3.48▲ | 3.31▲ | 2.60▲ |
| MA20 | 3.50▼ | 3.47▲ | 3.45▲ | 2.97▲ | 2.44▲ |
| MA50 | 3.43▲ | 3.48▲ | 3.43▲ | 2.40▲ | 2.15▲ |
| MA100 | 3.48▲ | 3.37▲ | 3.06▲ | 2.43▲ | 2.89▲ |
| MA200 | 3.47▲ | 3.00▲ | 2.67▲ | 2.10▲ | 14.42▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | 0.005▲ | 0.003▲ | 0.044▲ | 0.149▲ |
| RSI | 50.804▲ | 51.915▲ | 52.765▲ | 73.441▲ | 65.504▲ |
| STOCH | 27.723 | 60.450 | 74.649 | 80.999▲ | 84.566▲ |
| WILL %R | -66.667 | -39.130 | -23.684▲ | -21.105▲ | -12.442▲ |
| CCI | -75.490 | -20.776 | 38.791 | 77.002 | 162.102▲ |
|
Monday, June 16, 2025 12:15 PM
NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, and its subsidiary HOPE Therapeutics announced a strategic investor ...
|
|
Monday, June 16, 2025 11:30 AM
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. LOS ANGELES, CA - June 16, 2025 (NEWMEDIAWIRE) - NRx ...
|
|
Monday, June 16, 2025 05:03 AM
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 3.54 | 3.6099 | 3.44 | 3.48 | 190,748 |
| 13/06/25 | 3.17 | 3.50 | 3.14 | 3.44 | 358,054 |
| 12/06/25 | 3.47 | 3.50 | 3.23 | 3.44 | 325,588 |
| 11/06/25 | 3.70 | 3.75 | 3.475 | 3.48 | 277,737 |
| 10/06/25 | 3.60 | 3.705 | 3.43 | 3.67 | 573,327 |
| 09/06/25 | 3.30 | 3.75 | 3.30 | 3.67 | 775,518 |
| 06/06/25 | 3.02 | 3.28 | 2.95 | 3.27 | 405,228 |
| 05/06/25 | 2.98 | 3.04 | 2.82 | 2.94 | 295,329 |
| 04/06/25 | 2.75 | 2.98 | 2.75 | 2.95 | 362,971 |
| 03/06/25 | 2.70 | 2.76 | 2.55 | 2.72 | 204,637 |
|
|
||||
|
|
||||
|
|